Claims
- 1. An isolated nucleic acid molecule comprising a nucleotide sequence selected from:
a) the nucleotide sequence as set forth in SEQ ID NO: 1; b) the nucleotide sequence as set forth in SEQ ID NO: 5; c) the nucleotide sequence as set forth in SEQ ID NO: 7; d) the nucleotide sequence as set forth in SEQ ID NO: 11; and e) the nucleotide sequence as set forth in SEQ ID NO: 19.
- 2. The isolated nucleic acid molecule of claim 1, comprising a nucleotide sequence as set forth in SEQ ID NO: 5.
- 3. An isolated nucleic acid molecule comprising at least 300 contiguous bases of a nucleotide sequence selected from:
a) the nucleotide sequence as set forth in SEQ ID NO: 1; b) the nucleotide sequence as set forth in SEQ ID NO: 5; c) the nucleotide sequence as set forth in SEQ ID NO: 7; d) the nucleotide sequence as set forth in SEQ ID NO: 11; and e) the nucleotide sequence as set forth in SEQ ID NO: 19.
- 4. An isolated nucleic acid molecule comprising a nucleotide sequence encoding the amino acid sequence as set forth in SEQ ID NO: 6.
- 5. An isolated nucleic acid molecule comprising a nucleotide sequence encoding the amino acid sequence as set forth in SEQ ID NO: 2.
- 6. An isolated nucleic acid molecule comprising a nucleotide sequence encoding the amino acid sequence as set forth in SEQ ID NO: 8.
- 7. An isolated nucleic acid molecule comprising a nucleotide sequence encoding the amino acid sequence as set forth in SEQ ID NO: 12.
- 8. An isolated polypeptide comprising an amino acid sequence selected from:
a) the amino acid sequence as set forth in SEQ ID NO: 6; b) the amino acid sequence as set forth in SEQ ID NO: 2; c) the amino acid sequence as set forth in SEQ ID NO: 8; and d) the amino acid sequence as set forth in SEQ ID NO: 12.
- 9. An isolated polypeptide of claim 8, comprising an amino acid sequence as set forth in SEQ ID NO: 6.
- 10. An isolated polypeptide comprising an amino acid sequence selected from:
a) the amino acid sequence as set forth in SEQ ID NO: 6 with at least one conservative amino acid substitution; b) the amino acid sequence as set forth in SEQ ID NO: 2 with at least one conservative amino acid substitution; c) the amino acid sequence as set forth in SEQ ID NO: 8 with at least one conservative amino acid substitution; and d) the amino acid sequence as set forth in SEQ ID NO: 12 with at least one conservative amino acid substitution.
- 11. An isolated polypeptide of claim 10, comprising an amino acid sequence as set forth in SEQ ID NO: 6 with at least one conservative amino acid substitution.
- 12. A recombinant host cell containing an isolated nucleic acid molecule of any of claims 1, 2, 3, 4, 5, 6, or 7.
- 13. A recombinant host cell of claim 12, wherein the host cell is eukaryotic.
- 14. A recombinant host cell of claim 13, wherein the host cell is selected from CHO, VERO, BHK, HeLa, COS, MDCK, 293, 3T3, and WI38 cell lines.
Parent Case Info
[0001] The present application claims priority to U.S. Provisional Application No. 60/199,950, which was filed Apr. 27, 2000. The entire contents of U.S. Provisional Application No. 60/199,950 are incorporated by reference herein for any purpose.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60199950 |
Apr 2000 |
US |
Continuations (1)
|
Number |
Date |
Country |
Parent |
09843164 |
Apr 2001 |
US |
Child |
10394962 |
Mar 2003 |
US |